# name
Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management

# metadata.dc.description.abstract[].value
Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.

# metadata.dc.relation.ispartof[].value
International Journal of General Medicine, 2022, vol. 15, p. 8677-8684

# metadata.dc.rights[].value
cc by-nc (c) Vélez Santamaría, Valentina et al., 2022

# metadata.dc.source[].value
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

# metadata.dc.title[].value
Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management